We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Detects Breast Cancer at Earlier Stage

By MedImaging International staff writers
Posted on 31 Dec 2009
Magnetic resonance imaging (MRI) combined with mammography detects nearly all tumors at an early stage, thereby reducing the incidence of advanced stage breast cancer in high-risk women.

"Earlier stage breast cancers are more likely to be curable,” said lead researcher Ellen Warner, M.D., M.Sc., medical oncologist in the department of medicine, division of medical oncology at Sunnybrook Health Sciences Center (Toronto, Canada; Sunnybrook Health Sciences Center (Toronto, Canada). "We can be fairly confident that if screening with MRI finds cancers at a much earlier stage, it probably also saves lives,” added Dr. Warner, who presented details of these results at the CTRC-AACR San Antonio [TX, USA] Breast Cancer Symposium, held December 9-13, 2009.

The researchers separated 1,275 women at high risk for breast cancer into two groups: One group was screened with MRI scanning plus mammography, and the second, a control group, received conventional screening by mammography. Participants had the defective BRCA1 or BRCA2 gene mutation, which suggests a very high lifetime risk of developing breast cancer.

Dr. Warner and colleagues tracked the women over several years to determine which screening method detected cancer at a considerably earlier stage. Forty-one cases of breast cancer were diagnosed in the MRI group compared with 76 diagnoses in the control group. There were proportionately fewer advanced breast tumors, and more early cancers among women who screened with MRI compared with those not screened with MRI.

Furthermore, cancer size was smaller in the MRI group. The average size of invasive cancers in the MRI group was 0.9 cm compared to 1.8 cm in the control group. Three percent of cancers in the MRI group were larger than 2 cm in diameter compared with 29% of those in the control group.

"These results will hopefully convince high-risk women and their healthcare providers that breast screening with yearly MRI and mammography is a reasonable alternative to surgical removal of their breasts, which is commonly done to prevent breast cancer,” Dr. Warner said.

Related Links:
Sunnybrook Health Sciences Center


X-ray Diagnostic System
FDX Visionary-A
X-Ray Illuminator
X-Ray Viewbox Illuminators
Digital Radiography System
DR-300
Ultrasonic Pocket Doppler
SD1

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.